Immediate Impact
59 standout
Citing Papers
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
2025 Standout
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
Works of Herbert Diebolder being referenced
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer
2015
Loss of BRCA1 Protein Expression as Indicator of the BRCAness Phenotype Is Associated With Favorable Overall Survival After Complete Resection of Sporadic Ovarian Cancer
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Herbert Diebolder | 290 | 241 | 121 | 23 | 411 | |
| Ceyhun Numanoğlu | 256 | 243 | 131 | 34 | 428 | |
| Heung-Tat Ng | 223 | 221 | 107 | 16 | 440 | |
| Fuminori Ito | 205 | 212 | 35 | 23 | 349 | |
| A. Alvarez-Secord | 228 | 234 | 132 | 27 | 453 | |
| G Putignano | 124 | 173 | 120 | 25 | 408 | |
| Mohamed Hatem | 280 | 184 | 217 | 17 | 390 | |
| Marc P.L.M. Snijders | 252 | 257 | 54 | 30 | 405 | |
| J.T. Chambers | 221 | 203 | 60 | 23 | 353 | |
| M. Chirivella | 258 | 232 | 58 | 20 | 402 | |
| Hyo Sook Bae | 190 | 236 | 73 | 25 | 388 |
All Works
Loading papers...